ReviewInternational ophthalmology2026
Ocular TB as the only manifestation of TB: diagnostic uncertainty and treatment thresholds.
Review in International ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo review diagnostic approaches and treatment thresholds for presumed tuberculous uveitis when ocular inflammation is the only manifestation of tuberculosis (TB), focusing on phenotype-based risk stratification, interferon-gamma release assay (IGRA) interpretation, mimic exclusion, and evidence for antitubercular therapy (ATT).
methodsNarrative review using targeted PubMed search of ocular TB literature. Search terms included "ocular tuberculosis", "tuberculous uveitis", specific phenotypes (serpiginous-like choroiditis, retinal vasculitis, tuberculoma), and treatment outcomes. We prioritized consensus guidelines, systematic reviews, meta-analyses, and randomized data. Findings were synthesized into a phenotype-anchored diagnostic and treatment algorithm.
resultsOcular TB is usually diagnosed through a comprehensive assessment of ocular phenotype, epidemiologic risk, systemic evaluation, TB immunologic testing, and mimic exclusion. Higher-suspicion phenotypes include serpiginous-like choroiditis, occlusive retinal vasculitis, choroidal tuberculoma, anterior uveitis with iris nodules, and chronic granulomatous anterior uveitis in the appropriate clinical context. IGRA results support prior TB sensitization but do not establish ocular causality; positive results may be incidental, particularly in low-burden settings, while negative results do not fully exclude ocular TB when phenotype and epidemiologic context are strongly suggestive. Consensus guidance and recent randomized evidence support ATT in selected patients, but treatment thresholds remain phenotype- and context-dependent.
conclusionCompatible ocular phenotypes should prompt TB-directed evaluation, including IGRA and systemic assessment, with immunologic testing interpreted as supportive evidence. Treatment decisions should consider phenotype, epidemiological risk, mimic exclusion, and consequences of delayed treatment. High-risk presentations may justify lower treatment thresholds, while nonspecific ocular findings with isolated immunologic positivity should prompt consideration of alternative diagnoses or LTBI management according to local guidance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.